119 related articles for article (PubMed ID: 7832286)
1. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome.
Brand-Saberi B; Flöel H; Christ B; Schulte-Vallentin M; Schindler H
Ann Anat; 1994 Dec; 176(6):539-47. PubMed ID: 7832286
[TBL] [Abstract][Full Text] [Related]
2. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse.
von Kaisenberg CS; Krenn V; Ludwig M; Nicolaides KH; Brand-Saberi B
Anat Embryol (Berl); 1998 Feb; 197(2):105-24. PubMed ID: 9497154
[TBL] [Abstract][Full Text] [Related]
3. Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21.
Brand-Saberi B; Epperlein HH; Romanos GE; Christ B
Cell Tissue Res; 1994 Sep; 277(3):465-75. PubMed ID: 7954686
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonography of the fetal neck in the first and second trimesters. Part 2. Anomalies of the posterior nuchal region.
Suchet IB
Can Assoc Radiol J; 1995 Oct; 46(5):344-52. PubMed ID: 7552826
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls.
von Kaisenberg CS; Wilting J; Dörk T; Nicolaides KH; Meinhold-Heerlein I; Hillemanns P; Brand-Saberi B
Mol Hum Reprod; 2010 Oct; 16(10):778-89. PubMed ID: 20457798
[TBL] [Abstract][Full Text] [Related]
6. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk.
Bahado-Singh RO; Oz UA; Kovanci E; Deren O; Feather M; Hsu CD; Copel JA; Mahoney MJ
J Matern Fetal Med; 1999; 8(2):37-43. PubMed ID: 10090488
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.
Böhlandt S; von Kaisenberg CS; Wewetzer K; Christ B; Nicolaides KH; Brand-Saberi B
Hum Reprod; 2000 May; 15(5):1155-8. PubMed ID: 10783369
[TBL] [Abstract][Full Text] [Related]
8. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
9. Sonographic identification of second-trimester fetuses with Down's syndrome.
Benacerraf BR; Gelman R; Frigoletto FD
N Engl J Med; 1987 Nov; 317(22):1371-6. PubMed ID: 2960895
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic vessel hypoplasia in fetuses with Turner syndrome.
von Kaisenberg CS; Nicolaides KH; Brand-Saberi B
Hum Reprod; 1999 Mar; 14(3):823-6. PubMed ID: 10221720
[TBL] [Abstract][Full Text] [Related]
11. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
12. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
[TBL] [Abstract][Full Text] [Related]
13. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema.
Bekker MN; van den Akker NM; de Mooij YM; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
Reprod Sci; 2008 Apr; 15(3):295-304. PubMed ID: 18421024
[TBL] [Abstract][Full Text] [Related]
14. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
15. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
16. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous resolution of fetal cystic hygroma in Down's syndrome.
Rodis JF; Vintzileos AM; Campbell WA; Nochimson DJ
Obstet Gynecol; 1988 Jun; 71(6 Pt 2):976-7. PubMed ID: 2967453
[TBL] [Abstract][Full Text] [Related]
18. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
19. [Fetal neck edema--early sonographic indications of a chromosome abnormality].
Voigt HJ; Claussen U; Ulmer R
Geburtshilfe Frauenheilkd; 1986 Dec; 46(12):879-82. PubMed ID: 2950017
[TBL] [Abstract][Full Text] [Related]
20. Dermal fibroblasts from Down's syndrome patients share a cycloheximide-induced deficiency in collagen adhesion responses with normal aging cells.
Flickinger KS; Culp LA
Exp Cell Res; 1990 Aug; 189(2):189-201. PubMed ID: 2142462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
